Gland Pharma Ltd
Pharmaceuticals - Indian - Formulations
BSE Code:	543245	NSE Symbol:	GLAND	P/E :	25.92
ISIN Demat:	INE068V01023	Div & Yield %:	0.96	EPS :	72.04
Book Value:	610.02	Market Cap (Rs. Cr.):	30,761.67	Face Value :	1

Date	Headline
15-May-26	Board of Gland Pharma recommends final dividend
22-Apr-26	Gland Pharma to hold board meeting
04-Mar-26	Gland Pharma receives USFDA approval for Brimonidine Tartrate Ophthalmic Solution, 0.025%
18-Feb-26	Gland Pharma announces change in senior management
06-Feb-26	Gland Pharma receives USFDA approval for Zoledronic Acid Injection
10-Jan-26	Gland Pharma announces board meeting date
18-Oct-25	Gland Pharma schedules board meeting
26-Aug-25	Gland Pharma receives USFDA approval for Vasopressin in 5% Dextrose RTU Injection
22-Jul-25	Gland Pharma to discuss results
11-Jul-25	Gland Pharma's Pashamylaram facility receives GMP certification from Danish Medicines Agency

Company Snapshot